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Background: Extrauterine growth restriction (EUGR) plays an important role in the developmental origin of adult
cardiovascular diseases. In an EUGR rat model, we reported an elevated pulmonary arterial pressure in adults and
genome-wide epigenetic modifications in pulmonary vascular endothelial cells (PVECs). However, the underlying
mechanism of the early nutritional insult that results in pulmonary vascular consequences later in life remains unclear.
Methods: A rat model was used to investigate the physiological and structural effect of EUGR on early pulmonary
vasculature by evaluating right ventricular systolic pressure and pulmonary vascular density in male rats. Epigenetic
modifications of the Notch1 gene in PVECs were evaluated.
Results: EUGR decreased pulmonary vascular density with no significant impact on right ventricular systolic
pressure at 3 weeks. Decreased transcription of Notch1 was observed both at 3 and 9 weeks, in association with
decreased downstream target gene, Hes-1. Chromatin immunoprecipitation and bisulfite sequencing were
performed to analyze the epigenetic modifications of the Notch1 gene promoter in PVECs. EUGR caused a
significantly increased H3K27me3 in the proximal Notch1 gene promoter, and increased methylation of single
CpG sites in the distal Notch1 gene promoter, both at 3 and 9 weeks.
Conclusions: We conclude that EUGR results in decreased pulmonary vascular growth in association with
decreased Notch1 in PVECs. This may be mediated by increased CpG methylation and H3K27me3 in the Notch1
gene promoter region.
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Increased risk of adult-onset cardiovascular dysfunction
may originate from nutritional disturbances during crit-
ical windows of development [1], including prenatal
[2, 3] and early postnatal period [4–6]. Increasing evidence
also supports the early origins of later onset pulmonary
vascular disease. Infants with a transient perinatal insult
may develop pulmonary arterial hypertension early in
postnatal life [7], or be predisposed to an increased risk of
developing this disorder later in life [8]. In animal studies,
we recently addressed a strong association between mal-
nutrition during different critical windows and impaired* Correspondence: dulizhong@zju.edu.cn
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creativecommons.org/publicdomain/zero/1pulmonary vascular function in adulthood [9–11]. Intra-
uterine growth restriction (IUGR) resulted in aggravated
hypoxic pulmonary hypertension and vascular remodeling
[10], whereas extrauterine growth restriction (EUGR) rats
developed elevated pulmonary arterial pressure (PAP) in
the absence of a second-hit [11]. Although we and other
study [12] provide the evidence about developmental plas-
ticity of pulmonary vasculature, the precise mechanism is
still unknown.
In searching the mechanisms underlying these adult-
onset phenotypes, growing data support the hypothesis
that physiological adaptations in response to early nutri-
tional deprivation may induce permanent alterations of
structure in the developing cardiovascular system. Micro-
vascular rarefaction, a predictor of adverse cardiovascular
prognosis, has been observed in the very early stages ofcle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
ted. The Creative Commons Public Domain Dedication waiver (http://
.0/) applies to the data made available in this article, unless otherwise stated.
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arterial hypertension [16]. A strong association between
vascular rarefaction and nutritional programming of
elevated BP has also been addressed in adult animal
models [17–19]. However, whether EUGR exerts a
negative impact on early pulmonary vasculature in the
development of pulmonary arterial hypertension is
presently unknown.
Dysregulation of genes involved in impaired angio-
genesis may result in microvascular rarefaction. Notch1
signaling, predominantly in the endothelium, plays a
critical role in the development of the cardiovascular
system [20]. It has been validated as an essential con-
tributor to prenatal and postnatal angiogenesis [21, 22]
by activating downstream genes, such as transcription
factor hairy and enhancer of split-1(Hes-1) [23]. Notch1
is also identifiable in larger vessels in the embryonic
lung, finer alveolar vascular networks in later fetus, and
postnatal period [22, 24], suggesting an important role
in pulmonary vascular development.
Epigenetic regulation, including histone modification
and DNA methylation, plays a major part in the devel-
opmental origins of adult diseases [25, 26]. Our recent
studies revealed both IUGR and EUGR induced histone
modifications in the vascular tone regulators, endothelin-1
(ET-1) and endothelial nitric oxide synthase (eNOS)
[10, 11]. In addition, expression of key factors, peroxi-
some proliferator-activated receptor gamma (PPARγ)
and insulin-like growth factor-1 (IGF-1), were affected
by DNA methylation and histone modification following
EUGR [11]. In line with other evidence [27], we postu-
late that early nutritional experience has a wide impact
on the epigenetic modification of genes involved in
normal lung development and morphogenesis. An in-
creasing number of studies have documented the
epigenetic dysregulation of Notch1 in different tissues
and cells [28–30], including H3K9/14ace, H3K27me3
changes and DNA methylation at the gene promoter.
However, the epigenetic regulation of Notch1 in pul-
monary endothelium remains unclear.
In the present study, we sought to determine whether
EUGR affects the pulmonary vasculature, which may be
a contributor to pulmonary vascular dysfunction in
later life. We further hypothesized that dysregulation of
Notch1in pulmonary endothelium is involved in abnor-
mal alteration of vascular structure through epigenetic
adaptation secondary to EUGR.
Methods
Extrauterine growth restriction rat model
The EUGR rat model was established as described in
our previous study [11]. Briefly, pregnant Sprague–Dawley
rats were purchased from Zhejiang University Laboratory
Animal Center in Hangzhou, China, and maintained onstandard chow diets throughout gestation. Pups were
weighed within 24 h of birth and randomly assigned to
either a control litter, consisting of 8–10 pups, or a
larger litter consisting of 18–20 pups, both with a 1:1
male-to-female ratio. Pups were weaned on postnatal
day 21, and pups in the large litter whose weight was
below the 10th percentile of age-matched controls were
considered as EUGR [31]. Male rats were housed five
per cage and fed ad libitum. All procedures and experi-
ments were approved by The Animal Care and Use
Committee of Zhejiang University, China. Body weights
were recorded at 3, 6, and 9 weeks.
Pulmonary arterial pressure measurements
Right ventricular systolic pressure (RVSP) of rats at
3 weeks of age was evaluated as described previously
(we use RVSP to represent systolic pulmonary pressure
in 3-week-old animals in this study because for this
study group, it is not possible to insert a line into the
pulmonary artery at 3 weeks of age) [9]. Briefly, rats
were anesthetized with chloral hydrate (100–400 mg/kg,
intraperitoneally) and connected to a ventilator. Body
temperature was maintained at 38 °C. A PE21 catheter
was inserted into the right ventricle via the right jugular
vein, which was connected to a pressure transducer. RVSP
was recorded using a computer data acquisition system
(RM6240B/C, Chengdu Instruments, Chengdu, China).
For measurement of mean PAP, rats at 9 weeks of age
were anesthetized and placed on a thermo-regulated
surgical table. A PE-50 catheter with the angle directed
anteriorly was inserted from the right jugular vein
through the right heart into the main pulmonary artery.
Placement at each stage was confirmed by respective
pressure contours. Hemodynamic values were measured
and automatically calculated by a physiological data acqui-
sition system (Acknowledge MP150; Biopac System Inc.,
Goleta, California, USA) as described previously [11].
Immunohistochemistry and morphometric analysis
Left lungs were isolated from rats and inflated with ice-
cold 10 % formalin in phosphate-buffered saline (PBS)
and fixed for at least 48 h at 4 °C. Fixed lung tissue was
paraffin embedded, sectioned at 4–5 μm, and processed
for light microscopic immunohistochemistry. Samples
were incubated overnight with a primary antibody against
von-Willebrand factor (Dako, Glostrup, Denmark), an
endothelium marker, followed by a secondary antibody
(HRP polymer) for 30 min at 37 °C. At least five fields of
view from different lung sections per animal were evalu-
ated. Pulmonary vascular density was determined by
counting the number of positively stained small pul-
monary vessels (<50 μm) per high-powered field (× 200).
Sections of peripheral lung were examined, and fields
with large airways or major vessels were avoided. The
Tang et al. Respiratory Research  (2015) 16:66 Page 3 of 10measurements based on each field for each animal were
averaged to derive the mean number for that animal. The
mean for each animal was used for statistical analysis [32].
Isolation of pulmonary vascular endothelial cells
Rat pulmonary vascular endothelial cells (PVECs) were
isolated by magnetic-activated cell sorting (MACS) ac-
cording to the procedure in our previous study [10]. Rat
lungs were perfused with PBS into the trachea following
anesthetization and exsanguination via the abdominal
aorta. Fresh detached lung tissue was sliced into 1 mm
pieces and incubated in a 37 °C water bath with collage-
nase A. Lung cell suspensions were filtered, centrifuged,
and washed in MACS running buffer. The pellets were
resuspended in MACS running buffer, and then incu-
bated with PECAM-1 (BD PharMingen, San Diego,
California, USA) in a dark place for 15 min at 4 °C. After
washing twice, the pellets were resuspended and incubated
in anti-PE MicroBeads (Miltenyi Biotec, Bergisch Gladbach,
Germany). After washing, the final cell suspension was
added to a large column. Cells which were positively
labeled with magnetic microbeads and PECAM-1 anti-
body were selected using the separation unit, quickly
frozen in liquid nitrogen, and kept at −80 °C until use.
Total RNA isolation and quantitative RT-PCR
Total RNA and genomic DNA were simultaneously
purified from PVECs kept at −80 °C according to the
isolation kit protocol (Omega, Doraville, GA, USA). RNA
was reverse transcribed with a reverse transcriptase kit
(Takara, Dalian, China). Real-time quantitative PCR was
performed by LightCycler 480 Instrument (Roche, USA)
following the Takara SYBR-Green (Takara, Dalian, China)
protocol. β-Actin was used as an internal control. All
primers are shown (see Additional file 1: Table S1).
ChIP assay and ChIP qPCR
A chromatin immunoprecipitation (ChIP) assay was per-
formed as described previously [11]. Briefly, isolated
PVECs were fixed and cross-linked, and then lysed on
ice. Lysed extracts were subjected to shearing by sonic-
ation and centrifuged to collect the soluble protein-
chromatin complex. The soluble chromatin was divided
equally and incubated overnight with: anti-acetyl-H3K9
(Millipore 07–352, Billerica, MA, USA), anti-acetyl-H3K14
(Millipore 07-353, Billerica, MA, USA), anti-me3-H3K9
(Millipore 17–625, Billerica, MA, USA), and anti-me3-
H3K27 (Millipore 17–622, Billerica, MA, USA). The com-
plexes were precipitated with protein A-agarose beads and
incubated with NaCl to reverse DNA and protein crosslink.
Finally, DNA fragments were purified with a Qiagen DNA
extraction kit (Qiagen, Valencia, CA, USA). Relative quan-
tification of PCR products was based on value differences
between the bound and input using the ΔΔCt method.The primers used for ChIP qPCR are shown elsewhere
(see Additional file 1: Table S1).
Bisulfite sequencing
PVEC genomic DNA was extracted (Omega, Doraville,
GA, USA) and, according to the instructions of EpiTect
Bisulfite kit (Qiagen, Valencia, CA, USA), 2 μg was
treated with sodium bisulfite. Based on the different en-
richment peaks detected in the distal Notch1 gene pro-
moter previously [11], two significantly hypermethylated
regions within the peak were selected. The primers for
bisulfite sequencing (BS) of regions (BS1, BS2) are re-
ported (see Additional file 1: Table S1). At least 10
clones per sample were sequenced to assess the methyla-
tion state of the Notch1 gene promoter.
Statistical analysis
Repeated-measures ANOVA and student’s 2-tailed t-test
were used for independent samples. Correlation between
gene expression and DNA methylation was analyzed
using the Pearson test. A P value <0.05 was considered
statistically significant.
Results
Effect of extrauterine growth restriction on body weight
and pulmonary arterial pressure
There was no significant difference between the EUGR
and control rats for birth weight. After weaning at
3 weeks, the body weight of EUGR rats was significantly
less than that of the control rats (Fig. 1a, P = 0.0002). This
difference persisted in mature rats. Although weight gain
was greater in EUGR rats after weaning, compared with
controls, EUGR rats didn’t show a complete catch-up in
growth by 9 weeks (Fig. 1a, P = 0.016). RVSP of rats at
3 weeks of age, which represents systolic PAP in this
study, and PAP of 9 week-old rats were recorded to exam-
ine the effect of EUGR on hemodynamics. There were no
significant differences between EUGR and control rats
for RSVP at 3 weeks (20.92 ± 0.58 mmHg vs 20.40 ±
0.55 mmHg, P = 0.537, Fig. 1b). Mean PAP was increased
in the EUGR compared with the control group at 9 weeks
(25.72 ± 1.36 mmHg vs 20.83 ± 0.83 mmHg, P = 0.012,
Fig. 1c), which illustrated the effect of EUGR on PAP in
response to mismatched postnatal nutritional challenge, as
we reported previously [11].
Effect of extrauterine growth restriction on pulmonary
vascular density
Pulmonary vascular density (<50 μm) was measured by
immunohistochemical staining of von-Willebrand Factor
in five rats from each group at 3 weeks. The effects of
EUGR on postnatal pulmonary vascular density at 3 weeks
are shown in Fig. 2. Compared with controls, pulmonary
vascular density was decreased in the EUGR rats (Fig. 2c,
Fig. 1 Effect of extrauterine growth restriction (EUGR) on body weight, right ventricular systolic pressure (RVSP), and pulmonary arterial pressure
(PAP). a: Body weight from birth to 9 weeks of control and EUGR rats. Data are expressed as means ± SEM from 20–25 animals per group at each
time point. b: RVSP of 3- week-old rats. c: mean PAP (mPAP) of 9-week-old rats. Data are expressed as means ± SEM from 5 animals per group.
*P < 0.05, **P < 0.01
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vascular density were found in adulthood (data not shown).
Effect of extrauterine growth restriction on mRNA level of
Notch1 and downstream genes
Notch1 mRNA levels at different time points were
examined in PVECs. Compared with controls, Notch1
mRNA levels of EUGR rats were significantly decreased at
3 weeks (P = 0.031), and even lower at 9 weeks (P = 0.043,
Fig. 3a). To determine whether Notch1 signaling was
inhibited, the expression of Notch1 downstream targets
was also measured. Of the three main downstream genes,
Hes-1 was decreased at 3 weeks, consistent with reduced
Notch1 expression (Fig. 3b, P = 0.014), while there was no
between-group difference at 9 weeks (Fig. 3c, P = 0.270).
Effect of extrauterine growth restriction on histone
modification of proximal Notch1 gene promoter
To investigate EUGR-induced Notch1 epigenetic changes,
we analyzed DNA methylation and histone modification
patterns in the Notch1 gene promoter region in PVECs.
Combinations of histone modifications provide a measure
of transcriptionally active (H3K9ace, H3K14ace) and re-
pressed (H3K27me3) chromatin [24]. In this study, ChIP/real-time PCR was performed to examine the extent of
four H3 covalent modifications (H3K9ace, H3K14ace,
H3K9me3 and H3K27me3) at three regions in the prox-
imal promoter (Fig. 4a). At 3 weeks, compared with
controls, EUGR was associated with H3K27me3 at P1
(P = 0.033) and P2 (P = 0.037, Fig. 4b), whereas no dif-
ference was observed in other markers. In adult EUGR
rats, a significantly increased H3K27me3 at P2 (>10 fold,
P = 0.0498, Fig. 4c) was observed, in addition to increased
H3K9me3 at P1 (P = 0.016) and increased H3K14ace at P2
(P = 0.044, Fig. 4c). Both young and adult EUGR rats
exhibited significantly increased H3K27me3 at P1 and P2.
Effect of extrauterine growth restriction on CpG
methylation of Notch1 in the distal promoter
Cytosine methylation is a widespread DNA modification
mechanism, which is influenced by the environment and
affected by nutritional disturbance. Comprehensive ana-
lysis of DNA-methylation in PVECs was shown in a pre-
vious study by methyl-DNA immune precipitation chip
(MeDIP-chip) using a genome promoter array [11]. A
different enrichment peak exhibiting significant hyper-
methylation was detected at the distal promoter of the
Notch1 gene (Fig. 5a). To address the degree of altered
Fig. 2 Effects of EUGR on postnatal pulmonary vessel density after weaning. Representative lung histology from control (a) and EUGR (b) rats at
3 weeks, stained with von Willebrand factor (a marker of endothelium). Micrographs were obtained at the same magnification (200 ×). Internal
scale bar (50 μm). c: the number of von Willebrand factor-stained pulmonary vessels (diameter <50 μm) per high-power field decreased in EUGR
rats. Data are presented as mean ± SEM. (n = 5 rats per group). *P < 0.05
Tang et al. Respiratory Research  (2015) 16:66 Page 5 of 10methylation of a single CG site, we assayed the methyla-
tion status of this region using BS in PVECs. Five CpG
sites in BS1 and six in BS2 were analyzed within the differ-
ent enrichment peak. At 3 weeks, EUGR increased CpG
methylation at the −2488 CpG site (Fig. 5b, P = 0.026).Fig. 3 Expression levels of Notch1 gene (a), and ligands and downstream
control and EUGR male offspring rats at 3 and/or 9 weeks. Data are presen
assessed). *P < 0.05At 9 weeks, the −2805 (Fig. 5b, P = 0.019) and −2328 CpG
sites (Fig. 5e, P = 0.039) were significantly hypermethy-
lated. Although no significant difference was found at
other CpG sites, compared with control rats, more
than half of these sites showed a slight trend towardgenes (b and c) in pulmonary vascular endothelial cells (PVECs) of
ted as mean ± SEM. (PVECs from 6–8 rats of each group were
Fig. 4 Histone modifications of the Notch1 gene promoter in rats at 3 and 9 weeks. a Schematic illustration showing the different enrichment
peak (red bar) detected by Medip-chip in the distal promoter of the Notch1 gene and the region analyzed by bisulfite sequencing (BS) (blue bar).
ChIP-qPCR analysis of regions proximal to the transcription start site are also indicated (yellow bar). The distribution pattern of four histone modifications
at three sites in the proximal promoter (<−1500 bp) of Notch1 at (b) 3 weeks and (c) 9 weeks, analyzed by ChIP/real-time qPCR. Data are presented as
mean ± SEM. (PVECs from 9 rats of each group were assessed). *P< 0.05
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the EUGR rats, suggesting a general trend of hypermethy-
lation of this locus at the distal promoter of the Notch1
gene. The effect may persist from early life into adulthood.
The microarray data can be accessed from the Gene Ex-
pression Omnibus (GEO) site (http://www.ncbi.nlm.nih.-
gov/geo/) (accession number: GSE48648) [11].
We also attempted to correlate the degree of promoter
methylation to the mRNA expression level of Notch1
and found that mRNA expression was inversely associated
with methylation of BS1 (r2 = 0.82, P = 0.01) and CpG
site −2328 (r2 = 0.79, P = 0.02) (Fig. 6a and d) at 9 weeks,
while no significant correlations were observed be-
tween gene expression and methylation of BS2 (r2 = 0.51,
P = 0.11) and the CpG site −2805 (r2 = 0.60, P = 0.07)
(Fig. 6b and c). Despite slightly higher methylation at CpG
site −2488 in EUGR at 3 weeks, no correlation was found
(data not shown).
Discussion
In our prior work, we documented EUGR-induced
adult-onset pulmonary vascular dysfunction [11]. In thepresent study, we found that EUGR resulted in reduced
pulmonary vascular density during early postnatal life.
Decreased Notch1 expression in pulmonary endothe-
lium was associated with reduced vascular density,
which might be a consequence of altered epigenetic
modification secondary to EUGR, including histone
modification and DNA methylation at the Notch1 gene
promoter.
Postnatal nutritional insult is a trigger event in the
development of cardiovascular disease. Restriction of
prenatal and early postnatal growth may increase
systemic BP [33]. Our recent study demonstrated that
EUGR male rats developed elevated PAP [11], which,
for the first time, has been confirmed in the present
study. However, no effect was observed on RVSP at
3 weeks, suggesting adult-onset pulmonary hyperten-
sion induced by EUGR. Although little attention has
been paid in the literature concerning the negative im-
pact of EUGR on cardiovascular function, a recent study
[34] reported higher systolic and diastolic BP in pre-
pubertal children with a history of EUGR, which sup-
ports our result.
Fig. 5 Altered DNA methylation levels of distal CpG sites in Notch1 promoter in postnatal and adult rats. CpG methylation profile in the BS1, BS2
of 3-week-old (a-b) and 9-week-old rats (d-e). White bars represent control values, black bars represent EUGR. Representative methylation sample
are shown (c, f); each horizontal row of beads represents 11 CpG sites. Open circles indicate unmethylated CpG sites, while solid circles indicate
methylated CpG sites. *P < 0.05. Data are presented as mean ± SEM. (n = 3 rats per group)
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vascular density in EUGR rats at 3 weeks, but not at
9 weeks as adults, suggesting an early postnatal disruption
in pulmonary vasculature development, which was not yet
sufficient to cause measureable hemodynamic changes
in pulmonary circulation simultaneously. Rarefaction is
considered as a predictor of adverse long-term cardio-
vascular prognosis [35–37]. Further recent studies
demonstrated that impaired angiogenesis and periph-
eral muscle microcirculation rarefaction contribute to
pulmonary arterial hypertension [16, 38]. Although nei-
ther of our study, nor other studies, observed micro-
vascular rarefaction in adults [19], it has been reported
in the early stages, or even prior to hypertension, in
different organs [14, 39, 40]. Therefore, we postulate
that microvascular rarefaction is a primary event in
the development of nutritional programmed pulmonary
hypertension.
Rarefaction of microvessels is a consequence of im-
paired angiogenesis, partly attributing to dysregulationof major factors in vascular development. As a key
modulator, defects in endothelium Notch1 may result in
impaired postnatal vascularization [21]. In the present
study, we found significantly decreased Notch1 expres-
sion in PVECs in EUGR at 3 weeks compared with con-
trols. Furthermore, consistently reduced expression was
also observed in adult rats at 9 weeks. We detected
several downstream genes of Notch1 simultaneously.
Decreased Hes-1 expression corresponded with de-
creased Notch1 levels at 3 weeks, indicating Notch1-
mediated downregulation of Hes-1 following EUGR.
Our results show EUGR-related decreased Notch1
caused inhibition of Hes-1. However, further studies are
needed to elucidate how the dysfunction of Notch1 sig-
naling contributes to the disruption of pulmonary vas-
cular development.
Epigenetic adaptation, including histone modification
and DNA methylation, is an important molecular mech-
anism underlying perinatal insult-related cardio-metabolic
disorder [41, 42]. Histone acetylation often associates with
Fig. 6 Correlations between Notch1 gene promoter DNA methylation and the level of mRNA expression at 9 weeks. Pearson correlation for relative
gene expression and average DNA methylation of (a) BS1, (b) BS2. Correlation for relative gene expression and DNA methylation at (c) CpG site −2805,
(d) CpG site −2328
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whereas histone trimethylation at K9 and K27 is corre-
lated with gene silencing [43, 44], known as repressive
histone mark. In our current study, although H3K9me3
and H3K14ace were increased in EUGR adult rats,
H3K27me3 was more significantly increased at both 3 and
9 weeks in PVECs. In association with the consistently re-
duced Notch1 expression, our data suggest that repressive
histone mark (H3K27me3) plays a dominant role in
Notch1 gene expression. This is supported by a report of
significantly higher H3K27me3 in patients with systemic
lupus erythematosus [45]. Additionally, the persistent
trend of increased H3K27me3 at 3 and 9 weeks in the
present study implies a possible epigenetic adaptation in-
duced by EUGR.
Abnormal adaptation of DNA methylation during de-
velopment can persist into adulthood [46, 47]. Although
CpG islands at gene promoters are the most studied
regions of DNA methylation, isolated CpGs in the distal
promoter can also have regulatory significance [48].
Previously, MeDIP, and genome-wide microarrays (pro-
moter and CpG islands) were employed to identify a
genome methylation pattern in EUGR and control rats.
A significant hypermethylation peak was assessed in
the distal Notch1 gene promoter in PVECs of EUGRadult rats [11]. In the current study, BS was performed
to determine the degree of altered methylation of single
CpG sites in this region. We observed two CpG sites
with significantly increased methylation in EUGR rats,
such as the −2488 CpG site at 3 weeks, and the −2805
and −2328 CpG sites at 9 weeks. Considering the
significantly increased H3K27me3 in our study, epigen-
etic down-regulation of Notch1 seems to be mediated
by a combination of DNA methylation and histone
modification [45]. Although the relatively modest
increase of Notch1 DNA methylation in EUGR is not
surprising, a significantly inverse correlation was dem-
onstrated between the degree of methylation of BS1,
CpG site −2328 and Notch1 gene expression. There-
fore, our result gives new insights into the environ-
mental stress-sensitive regulating region of the Notch1
gene in the distal promoter through altered DNA
methylation.
Finally, the limitation of this study should be ad-
dressed. Although we have now provided evidence that
EUGR-induced epigenetic down-regulation of Notch1
may contribute to pulmonary vascular rarefaction, the
mechanism underlying these altered epigenetic mo-
dification is still unclear. The epigenetic pattern is
usually governed by specialized enzymes, including
Tang et al. Respiratory Research  (2015) 16:66 Page 9 of 10histone deacetylase, histone methytransferases and
DNA methyltransferases. It has been demonstrated
that abnormal Notch1 gene expression involves altered
recruitment of these enzymes, such as enhancer of
zeste homolog 2 (EZH2) and DNA methyltransferase
(DNMT-3b), to promoter regions and/or additional
cis-regulatory regions in the Notch1 gene [30]. There-
fore, future studies need to elucidate the underlying
mechanism.
Conclusion
Our findings indicate that EUGR-induced decreased
pulmonary vascular density in early postnatal life
correlates with decreased Notch1 gene expression in
endothelial cells. Furthermore, we documented that a
combination of epigenetic adaptations, including in-
creased H3K27me3 in the proximal promoter and
hypermethylation of CpG sites in the distal promoter,
were associated with decreased Notch1 expression and
its target gene, Hes-1. More importantly, we provide
new evidence that pulmonary vascular rarefaction is an
important predictive event in the early nutritional pro-
gramming of elevated PAP.
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